Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma | Zendy

Marine Baron | Zendy; Lisa Belin | Zendy; Nathalie Cassoux | Zendy; Christine Fardeau | Zendy; M. Blaizeau | Zendy; Carole Soussain | Zendy; Caroline Houillier | Zendy; Khê HoangXuan | Zendy; Emmanuel Gyan | Zendy; MarieLaure Le Lez | Zendy; Anne Lavaud | Zendy; Pierre Soubeyran | Zendy; Bahram Bodaghi | Zendy; Myrto Costopoulos | Zendy; Véronique Leblond | Zendy; Valérie Touitou | Zendy; Karim Maloum | Zendy; MarieHélène Errera | Zendy; Damien RoosWeil | Zendy; Magali Le GarffTavernier | Zendy; Sylvain Choquet | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Author(s) -

Marine Baron,

Lisa Belin,

Nathalie Cassoux,

Christine Fardeau,

M. Blaizeau,

Carole Soussain,

Caroline Houillier,

Khê HoangXuan,

Emmanuel Gyan,

MarieLaure Le Lez,

Anne Lavaud,

Pierre Soubeyran,

Bahram Bodaghi,

Myrto Costopoulos,

Véronique Leblond,

Valérie Touitou,

Karim Maloum,

MarieHélène Errera,

Damien RoosWeil,

Magali Le GarffTavernier,

Sylvain Choquet

Publication year - 2020

Publication title -

blood

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.515

H-Index - 465

eISSN - 1528-0020

pISSN - 0006-4971

DOI - 10.1182/blood.2019003073

Subject(s) - temozolomide , medicine , lymphoma , refractory (planetary science) , oncology , dacarbazine , surgery , chemotherapy , physics , astrobiology

Baron et al report excellent responses to temozolomide in 21 patients (19 relapsed/refractory) with primary vitreoretinal lymphoma. Treatment is well tolerated, even in elderly patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research